Federal regulators recently made a controversial decision regarding e-cigarettes and nicotine pouches. The Food and Drug Administration (FDA) authorized the sale of fruit-flavored vapes in the United States. This decision marks a change in policy, allowing a manufacturer to produce mango and blueberry-flavored electronic cigarettes, despite previous warnings about the risks these products pose to children and teenagers.

Earlier this month, the FDA’s authorization came as a surprise to many public health advocates. The approval of these products contradicts years of insistence by health officials that fruit-flavored vapes present a unique danger, contributing to an increase in underage vaping.

The American Academy of Pediatrics, alongside several other public health organizations, criticized the FDA’s decision. They argue that flavored e-cigarettes can be particularly appealing to youths, leading to higher rates of smoking initiation and possible nicotine addiction.

These concerns are grounded in past research and reported instances of increased vaping among teenagers, following the advent of flavored nicotine products. Health professionals continue to warn that such flavors might mask the harm nicotine can cause, making it more likely for adolescents to try these products.

Despite objections, the FDA proceeded with its authorization, sparking a debate among health experts about the potential impact on public health and the safety of young individuals.